Wolverine Trading
AXDX

Wolverine Trading’s Accelerate Diagnostics AXDX Stock Holding History

Wolverine Trading’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,329
Closed -$9K – 4232
2023
Q1 		$9K Buy
+1,329
New +$7.99K ﹤0.01% 4078
2021
Q2 		– Sell
-1,504
Closed -$122K – 5925
2021
Q1 		$122K Sell
1,504
-720
-32% -$73K ﹤0.01% 5343
2020
Q4 		$166K Buy
2,224
+931
+72% +$83.4K ﹤0.01% 4320
2020
Q3 		$140K Sell
1,293
-2,211
-63% -$307K ﹤0.01% 4000
2020
Q2 		$506K Buy
+3,504
New +$345K ﹤0.01% 2708
2020
Q1 		– Sell
-1,674
Closed -$236K – 4600
2019
Q4 		$279K Buy
+1,674
New +$276K ﹤0.01% 3678
2019
Q3 		– Sell
-909
Closed -$176K – 4301
2019
Q2 		$208K Sell
909
-347
-28% -$67.9K ﹤0.01% 3679
2019
Q1 		$264K Sell
1,256
-1,939
-61% -$364K ﹤0.01% 3511
2018
Q4 		$376K Buy
3,195
+894
+39% +$132K ﹤0.01% 2921
2018
Q3 		$528K Buy
+2,301
New +$509K ﹤0.01% 3051
2018
Q1 		– Sell
-1,275
Closed -$335K – 5089
2017
Q4 		$334K Sell
1,275
-800
-39% -$188K ﹤0.01% 3469
2017
Q3 		$466K Buy
2,075
+128
+7% +$31.4K ﹤0.01% 2685
2017
Q2 		$530K Buy
1,947
+762
+64% +$207K ﹤0.01% 2375
2017
Q1 		$286K Buy
+1,185
New +$271K ﹤0.01% 3079

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wolverine Trading's AXDX Position: Q2 2023 in Review

Wolverine Trading sold out of Accelerate Diagnostics (AXDX) in Q2 2023, closing a stake of 1,329 shares — an estimated $9K sold.

Wolverine Trading first reported a position in AXDX in Q1 2017 and held it in 14 quarters. The position peaked at $530K in Q2 2017. 51 funds tracked by Wall St. Rank hold AXDX as of Q2 2023.

  • Wolverine Trading reported no remaining Accelerate Diagnostics position as of Q2 2023 after selling out during the quarter.
  • Wolverine Trading sold 1,329 Accelerate Diagnostics shares in Q2 2023, an estimated $9K.
  • Wolverine Trading first reported a position in Accelerate Diagnostics in Q1 2017 and held it in 14 quarters.
  • Wolverine Trading's Accelerate Diagnostics position peaked at $530K in Q2 2017.
  • 51 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.